TY  - RPRT
TI  - IL-6R blockade with tocilizumab disrupts pericyte-and tumor cell-driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer
AU  - Przanowska, R. K.
AU  - Gomez-Villa, J.
AU  - Liu, V. J.
AU  - Antonides-Jensen, N.
AU  - Visvabharathy, L.
AU  - Alverdy, J. C.
AU  - Hernandez, S. L.
AU  - Yee, S. S.
PY  - 2026
DO  - 10.64898/2026.01.29.702661
UR  - https://www.biorxiv.org/content/10.64898/2026.01.29.702661v1
ID  - 10.64898/2026.01.29.702661
ER  -